말초동맥질환 시장 보고서 : 유형, 최종사용자, 지역별(2025-2033년)

The global peripheral artery disease market size reached USD 4.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 7.7 Billion by 2033, exhibiting a growth rate (CAGR) of 4.98% during 2025-2033. The rising number of geriatric populations, various technological innovations in the diagnosis and treatment, increasing adoption of home care settings, improvement in healthcare infrastructure, and changing living standards of individuals are propelling the market growth.

Peripheral artery disease (PAD) is a cardiovascular disorder wherein constricted arteries restrict blood flow to the limbs. It results in hair loss, leg numbness, feet or toe sores, painful cramps in hips and thighs, coldness and weak pulse in legs, and erectile dysfunction among men. It is caused when a plaque, also known as atherosclerosis, develops in leg arteries that carry oxygen and nutrient-rich blood from the heart to the arms and legs. It is diagnosed using the ankle-brachial index, ultrasound scan, angiography, blood tests, doppler and ultrasound (duplex) imaging, computed tomographic angiography (CT), and magnetic resonance angiography (MRA). The peripheral artery disease market overview indicates an increasing demand for advanced diagnostic and treatment options, as rising awareness and the growing prevalence of risk factors such as diabetes and hypertension are pushing for more effective solutions in managing and treating PAD.

Peripheral Artery Disease Market Trends:

Technological Advancements in Minimally Invasive Surgeries

The development of sophisticated catheter-based devices and techniques is revolutionizing vascular interventions, offering less invasive alternatives to traditional open surgeries. These advancements are significantly improving treatment outcomes by reducing patient discomfort, shortening hospital stays, and enabling faster recovery times. New devices, such as advanced angioplasty balloons, drug-coated balloons, atherectomy devices, and specialized stents, are expanding the range of treatment options available for PAD. These innovations offer greater flexibility, deliverability, and efficacy, allowing clinicians to treat complex lesions more effectively. Furthermore, these less invasive procedures preserve normal vascular anatomy while improving long-term patency rates, leading to better overall outcomes. The peripheral artery disease market trends show a shift towards more advanced, patient-friendly treatment options, with increasing demand for innovative devices that enable better clinical results and improved quality of life for PAD patients.

Changing Living Standards of Individuals

People are increasingly suffering from peripheral artery disease (PAD) due to lifestyle-related factors, such as diabetes, obesity, hypertension, and smoking. As global rates of these conditions increase, particularly in regions with aging populations, more individuals are at risk of PAD. Diabetes contributes to atherosclerosis, which narrows arteries and restricts blood flow, leading to PAD. As a result, the demand for diagnostic tools and treatments, such as angioplasty, stenting, and bypass surgery, is rising. Additionally, the global burden of cardiovascular diseases (CVDs) is pushing healthcare systems to focus on early detection and management of PAD.

Aging Population

The global aging population across the globe is a crucial factor impelling the market growth. Older adults face a higher risk of developing PAD owing to age-related vascular changes and atherosclerosis. As people age, their arteries naturally lose elasticity, which can result in narrowed or blocked arteries, a hallmark of PAD. This demographic shift drives demand for healthcare services including diagnostics, preventive treatments, and minimally invasive (MI) interventions like angioplasty and stent placement. In line with this, healthcare providers are increasingly focusing on addressing the needs of elderly patients, who often have complex health profiles, which is thereby contributing to the peripheral artery disease market growth.

Key Market Segmentation:

Breakup by Type:

• Peripheral Angioplasty Balloons
• Peripheral Stents
• Peripheral Catheters
• Inferior Vena Cava (IVC) Filters
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Peripheral Accessories

Breakup by End User:

• Hospitals
• Specialty Clinics
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The peripheral artery disease market research report has also provided a comprehensive analysis of the competitive landscape in the global market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

• Abbott Laboratories
• AngioDynamics
• B. Braun Melsungen AG
• Becton Dickinson and Company
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardinal Health Inc.
• Cook Medical LLC
• Koninklijke Philips N.V.
• Medtronic plc
• Terumo Corporation

Key Questions Answered in This Report

• 1.How big is the global peripheral artery disease market?
• 2.What is the expected growth rate of the global peripheral artery disease market during 2025-2033?
• 3.What are the key factors driving the global peripheral artery disease market?
• 4.What has been the impact of COVID-19 on the global peripheral artery disease market?
• 5.What is the breakup of the global peripheral artery disease market based on the type?
• 6.What are the key regions in the global peripheral artery disease market?
• 7.Who are the key players/companies in the global peripheral artery disease market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Peripheral Artery Disease Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Type

• 6.1 Peripheral Angioplasty Balloons
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Peripheral Stents
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Peripheral Catheters
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Inferior Vena Cava (IVC) Filters
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Plaque Modification Devices
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Hemodynamic Flow Alteration Devices
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast
• 6.7 Peripheral Accessories
  • 6.7.1 Market Trends
  • 6.7.2 Market Forecast

7 Market Breakup by End User

• 7.1 Hospitals
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Specialty Clinics
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Others
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast

8 Market Breakup by Region

• 8.1 North America
  • 8.1.1 United States
    • 8.1.1.1 Market Trends
    • 8.1.1.2 Market Forecast
  • 8.1.2 Canada
    • 8.1.2.1 Market Trends
    • 8.1.2.2 Market Forecast
• 8.2 Asia-Pacific
  • 8.2.1 China
    • 8.2.1.1 Market Trends
    • 8.2.1.2 Market Forecast
  • 8.2.2 Japan
    • 8.2.2.1 Market Trends
    • 8.2.2.2 Market Forecast
  • 8.2.3 India
    • 8.2.3.1 Market Trends
    • 8.2.3.2 Market Forecast
  • 8.2.4 South Korea
    • 8.2.4.1 Market Trends
    • 8.2.4.2 Market Forecast
  • 8.2.5 Australia
    • 8.2.5.1 Market Trends
    • 8.2.5.2 Market Forecast
  • 8.2.6 Indonesia
    • 8.2.6.1 Market Trends
    • 8.2.6.2 Market Forecast
  • 8.2.7 Others
    • 8.2.7.1 Market Trends
    • 8.2.7.2 Market Forecast
• 8.3 Europe
  • 8.3.1 Germany
    • 8.3.1.1 Market Trends
    • 8.3.1.2 Market Forecast
  • 8.3.2 France
    • 8.3.2.1 Market Trends
    • 8.3.2.2 Market Forecast
  • 8.3.3 United Kingdom
    • 8.3.3.1 Market Trends
    • 8.3.3.2 Market Forecast
  • 8.3.4 Italy
    • 8.3.4.1 Market Trends
    • 8.3.4.2 Market Forecast
  • 8.3.5 Spain
    • 8.3.5.1 Market Trends
    • 8.3.5.2 Market Forecast
  • 8.3.6 Russia
    • 8.3.6.1 Market Trends
    • 8.3.6.2 Market Forecast
  • 8.3.7 Others
    • 8.3.7.1 Market Trends
    • 8.3.7.2 Market Forecast
• 8.4 Latin America
  • 8.4.1 Brazil
    • 8.4.1.1 Market Trends
    • 8.4.1.2 Market Forecast
  • 8.4.2 Mexico
    • 8.4.2.1 Market Trends
    • 8.4.2.2 Market Forecast
  • 8.4.3 Others
    • 8.4.3.1 Market Trends
    • 8.4.3.2 Market Forecast
• 8.5 Middle East and Africa
  • 8.5.1 Market Trends
  • 8.5.2 Market Breakup by Country
  • 8.5.3 Market Forecast

9 SWOT Analysis

• 9.1 Overview
• 9.2 Strengths
• 9.3 Weaknesses
• 9.4 Opportunities
• 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

• 11.1 Overview
• 11.2 Bargaining Power of Buyers
• 11.3 Bargaining Power of Suppliers
• 11.4 Degree of Competition
• 11.5 Threat of New Entrants
• 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

• 13.1 Market Structure
• 13.2 Key Players
• 13.3 Profiles of Key Players
  • 13.3.1 Abbott Laboratories
    • 13.3.1.1 Company Overview
    • 13.3.1.2 Product Portfolio
    • 13.3.1.3 Financials
    • 13.3.1.4 SWOT Analysis
  • 13.3.2 AngioDynamics
    • 13.3.2.1 Company Overview
    • 13.3.2.2 Product Portfolio
    • 13.3.2.3 Financials
    • 13.3.2.4 SWOT Analysis
  • 13.3.3 B. Braun Melsungen AG
    • 13.3.3.1 Company Overview
    • 13.3.3.2 Product Portfolio
    • 13.3.3.3 SWOT Analysis
  • 13.3.4 Becton Dickinson and Company
    • 13.3.4.1 Company Overview
    • 13.3.4.2 Product Portfolio
    • 13.3.4.3 Financials
    • 13.3.4.4 SWOT Analysis
  • 13.3.5 Biotronik SE & Co. KG
    • 13.3.5.1 Company Overview
    • 13.3.5.2 Product Portfolio
    • 13.3.5.3 SWOT Analysis
  • 13.3.6 Boston Scientific Corporation
    • 13.3.6.1 Company Overview
    • 13.3.6.2 Product Portfolio
    • 13.3.6.3 Financials
  • 13.3.7 Cardinal Health Inc.
    • 13.3.7.1 Company Overview
    • 13.3.7.2 Product Portfolio
    • 13.3.7.3 Financials
    • 13.3.7.4 SWOT Analysis
  • 13.3.8 Cook Medical LLC
    • 13.3.8.1 Company Overview
    • 13.3.8.2 Product Portfolio
    • 13.3.8.3 SWOT Analysis
  • 13.3.9 Koninklijke Philips N.V.
    • 13.3.9.1 Company Overview
    • 13.3.9.2 Product Portfolio
    • 13.3.9.3 Financials
    • 13.3.9.4 SWOT Analysis
  • 13.3.10 Medtronic plc
    • 13.3.10.1 Company Overview
    • 13.3.10.2 Product Portfolio
    • 13.3.10.3 Financials
    • 13.3.10.4 SWOT Analysis
  • 13.3.11 Terumo Corporation
    • 13.3.11.1 Company Overview
    • 13.3.11.2 Product Portfolio
    • 13.3.11.3 Financials
    • 13.3.11.4 SWOT Analysis